BryanJohnMcColganMD
Endocrinology • Oakland, CALipid Metabolism
Endocrionologist | Clinical Research | Digital Health
Dr. McColgan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1270 Excelsior Avenue
Oakland, CA 94610- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
Certifications & Licensure
NY State Medical License 2013 - 2025
CA State Medical License 2014 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
- Member Gold Humanism Honor Society, 2011
- Member Alpha Omega Alpha Honor Society, 2011
Clinical Trials
- Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2016 Jun 13
- Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2016 Oct 26
- Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis Start of enrollment: 2016 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials.Sanyal, A. J.,Harrison, S. A.,Ratziu, V.,Abdelmalek, M. F.,Diehl, A. M.,Caldwell, S.,Shiffman, M. L.,Schall, R. A.,Jia, C.,McColgan, B.,Djedjos, C. S.,McHutchison, J. ...> ;Hepatology. 2019 Apr 18
- 103 citationsSimtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the DiseaseAndrew J. Muir, Cynthia Levy, Harry L.A. Janssen, Aldo J. Montano-Loza, Mitchell L. Shiffman, Stephen H. Caldwell, Velimir A. Luketic, D. Ding, Catherine Jia, B. Mccol...> ;Hepatology. 2019 Feb 1
- 137 citationsAcetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis.Eric Lawitz, Angie Coste, Fred Poordad, Naim Alkhouri, Nicole Loo, B. Mccolgan, Jacqueline M. Tarrant, T. Nguyen, Ling Han, Chuhan Chung, Adrian S. Ray, John G. McHutc...> ;Clinical Gastroenterology and Hepatology. 2018 Dec 1
- Join now to see all
Professional Memberships
- Fellow
External Links
- Online Portfoliohttp://www.bryanmccolgan.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
